Dr. Tyrone C. Malloy: Urology-Urinary Incontinence

Continued                              A Phase 3, Randomized, Double Blind, Parallel Group Active Controlled, Multi-Center Long-Term Study to Assess the Efficacy and Safety of the Beta-3 Agonist X in Subjects with Symptoms of Overactive Bladder

                                    Principal Investigator

Sponsor: Astellas Phrama US

A Phase 3, Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study to Assess the Efficacy and Safety of the Beta-3 Agonist X in Subjects with Symptoms of Overactive Bladder

                                    Principal Investigator

Sponsor: Astellas Phrama US

Study of XXX  In Women Of Different Demographic Characteristics And Co-Morbidities with Stress Urinary Incontinence: Evaluation of Efficacy and Safety.

                                                Principal Investigator

                                                Sponsor: Eli Lilly                                          

Symptom Specific Effectiveness of XX in Patients with

Symptoms of Overactive Bladder (OAB) in a Primary Care Setting.  A Phase 4, Open Label, Single Arm, Non-Randomized Trial in Adult Patients with OAB

                                                Principal Investigator

                                                Sponsor: Pfizer

A randomized double-blind placebo and active Controlled efficacy and safety study of XX in patients with overactive bladder or urge urinary incontinence

Principal Investigator

                                                Sponsor: Sanofi-Aventis

A Multi-Center, Double-Blind, Placebo-Controlled Study of the Efficacy and Safety of Daily Dosing with XXXXX Topical Gel to Treat the Symptoms of Overactive Bladder

Principal Investigator

Sponsor: Watson Pharmaceutical

A Randomized, Double-Blind, Placebo-Controlled, Multicenter, Parallel Group Evaluation of the Efficacy and Safety of 50 mg, 100 mg and 200 mg XXXX Twice Daily for the Treatment of Burning During Urination, Pain, and Urination Frequency Associated with Uncomplicated Urinary Tract Infection.

Principal Investigator

Sponsor: Pennacle

Dr. Tyrone Malloy: Urinary Incontinence